International Symposium on virological aspects of the safety of biological products
Author(s)
Bibliographic Information
International Symposium on virological aspects of the safety of biological products
(Developments in biological standardization, v. 75)
Karger, c1991
- Other Title
-
Virological aspects of the safety of biologicalproducts
Available at 2 libraries
  Aomori
  Iwate
  Miyagi
  Akita
  Yamagata
  Fukushima
  Ibaraki
  Tochigi
  Gunma
  Saitama
  Chiba
  Tokyo
  Kanagawa
  Niigata
  Toyama
  Ishikawa
  Fukui
  Yamanashi
  Nagano
  Gifu
  Shizuoka
  Aichi
  Mie
  Shiga
  Kyoto
  Osaka
  Hyogo
  Nara
  Wakayama
  Tottori
  Shimane
  Okayama
  Hiroshima
  Yamaguchi
  Tokushima
  Kagawa
  Ehime
  Kochi
  Fukuoka
  Saga
  Nagasaki
  Kumamoto
  Oita
  Miyazaki
  Kagoshima
  Okinawa
  Korea
  China
  Thailand
  United Kingdom
  Germany
  Switzerland
  France
  Belgium
  Netherlands
  Sweden
  Norway
  United States of America
Description and Table of Contents
Description
Despite the fact that biologicals have since early times been involved in many adverse reactions, the common efforts of producers, regulatory agencies and scientists have succeeded in recent decades in significantly reducing the number of clinical accidents induced by these products. However, the infection of patients with HIV after administration of blood derivatives and an increasing number of cases of Creutzfeldt-Jakob disease after treatment with human pituitary growth hormone clearly shows that safety is still the main issue in using biologicals. This volume focuses on virological aspects of the safety of biological products. Sections cover regulatory policy, virus inactivation as well as viral contamination and detection. Other sections address the special problems posed by retroviruses and BSE and related agents. As it is very probable that the number of biologicals used in humans will increase to parallel the rapid progress in biomedical research, this update contains important information from virologists and those concerned with the development, production and regulation of these products.
Table of Contents
- Safety of biologicals - regulatory approach
- virus inactivation
- BSE and related agents
- retroviruses
- viral contamination and detection
- regulatory aspects of virus safety.
by "Nielsen BookData"